{"id":"NCT02612129","sponsor":"ZevraDenmark","briefTitle":"Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C","officialTitle":"Arimoclomol Prospective Double-blind, Randomised, Placebo-controlled Study in Patients Diagnosed With Niemann-Pick Disease Type C","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-06-14","primaryCompletion":"2018-06-25","completion":"2024-10-31","firstPosted":"2015-11-23","resultsPosted":"2023-06-09","lastUpdate":"2024-11-29"},"enrollment":50,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Niemann-Pick Disease, Type C"],"interventions":[{"type":"DRUG","name":"arimoclomol","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Arimoclomol Single PK Dose","type":"EXPERIMENTAL"},{"label":"Arimoclomol (12-month Double-blind Phase)","type":"EXPERIMENTAL"},{"label":"Placebo (12-month Double-blind Phase)","type":"PLACEBO_COMPARATOR"}],"summary":"A prospective, randomized, double-blind, placebo controlled therapeutic study in participants with confirmed diagnosis of Niemann-Pick disease type C (NPC).\n\nThe purpose of this study is to assess the efficacy and safety of arimoclomol (compared to placebo) when it is administered as an add-on therapy to the participant's current prescribed best routine clinical care; participant's routine clinical care may, or may not, include miglustat.\n\nThe CT-ORZY-NPC-002 study has been expanded to include an open label paediatric sub-study including participants aged 6 to \\<24 months at study enrolment.","primaryOutcome":{"measure":"Change From Baseline in the Niemann-Pick Disease Type C (NPC) Disease Severity Assessed Based on the 5-domain NPCCSS Total Scores","timeFrame":"Baseline to Month 12","effectByArm":[{"arm":"Arimoclomol (12-month Double-blind Phase)","deltaMin":0.76,"sd":null},{"arm":"Placebo (12-month Double-blind Phase)","deltaMin":2.15,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0456"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":14,"countries":["United States","Denmark","France","Germany","Italy","Poland","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["33579322","34418116"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":28},"commonTop":["Vomiting","Pyrexia","Constipation","Diarrhoea","Upper Respiratory Tract Infection"]}}